BDBM50168291 CHEMBL363350::Sodium; {3-[(S)-2-(4,5-diphenyl-oxazol-2-yl)-cyclopent-2-enylmethyl]-phenoxy}-acetate
SMILES: [O-]C(=O)COc1cccc(C[C@@H]2CCC=C2c2nc(c(o2)-c2ccccc2)-c2ccccc2)c1
InChI Key: InChIKey=YRGGCMQENORWIL-QHCPKHFHSA-M
Data: 1 KI
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prostanoid IP receptor (Homo sapiens (Human)) | BDBM50168291 (CHEMBL363350 | Sodium; {3-[(S)-2-(4,5-diphenyl-oxa...) | NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | 41 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Fujisawa Pharmaceutical Co., Ltd. Curated by ChEMBL | Assay Description Inhibition of [3H]-Iloprost binding to human Prostanoid IP receptor | Bioorg Med Chem Lett 15: 3284-7 (2005) Article DOI: 10.1016/j.bmcl.2005.04.076 BindingDB Entry DOI: 10.7270/Q2C53KCV | |||||||||||
More data for this Ligand-Target Pair |